dragonfly discovery to enable and accelerate early-stage drug discovery processes

25 Feb 2020

In this scientific poster, SPT Labtech demonstrates how the dragonfly® discovery is able to enable and accelerate early-stage drug discovery processes. This poster addresses a wide range of applications within functional genomics, phenotypic and biochemical assay workflows.

dragonfly® discovery

SPT Labtech

dragonfly discovery enables innovative, low volume liquid dispensing that is compatible with a wide range of applications including molecular biology and genomics, biochemical assays, as well as cell- and bead-based assays. 

(3)

Links

Tags

Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.
dragonfly discovery to enable and accelerate early-stage drug discovery processes